UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Serum sFas, Leptin, and VEGF in Patients with Ovarian Cancer and Benign Tumors

Bulletin of experimental biology and medicine, 2009-11, Vol.148 (5), p.810-814

2009

Volltextzugriff (PDF)

Cancer and Soluble FAS

Bulletin of experimental biology and medicine, 2009-10, Vol.148 (4), p.638-642

2009

Volltextzugriff (PDF)

Method development and validation for determination of antihemolytic activity of eculizumab (Soliris)

Farmaciâ i Farmakologiâ (Pâtigorsk), 2017-03, Vol.4 (6), p.54-71

2017

Volltextzugriff (PDF)

Monoclonal antibodies against the propeptide of endopeptidase AlpB of Lysobacter sp. XL1 for studying AlpB-protein interactions in bacterial cells

Doklady. Biochemistry and biophysics, 2011-12, Vol.441 (1), p.298-301

2011

Volltextzugriff (PDF)

Soluble Fas antigen in the serum of patients with colon cancer

Bulletin of experimental biology and medicine, 2001-04, Vol.131 (4), p.361-363

2001

Volltextzugriff (PDF)

Changes in the balance between membrane-bound and soluble forms of CD95 (Fas) during selection of tumor cells in vivo

Biochemistry (Moscow), 2002-02, Vol.67 (2), p.240-245

2002

Volltextzugriff (PDF)

Epitope mapping of human Fas using peptide phage display

Bulletin of experimental biology and medicine, 2007-10, Vol.144 (4), p.515-519

2007

Volltextzugriff (PDF)

Plasma content of soluble fas antigen in patients with adrenal tumors and tumor-like pathologies

Bulletin of experimental biology and medicine, 2002-08, Vol.134 (2), p.171-174

2002

Volltextzugriff (PDF)

Soluble Fas antigen (sFAS) in the serum from patients with adrenal tumors

Bulletin of experimental biology and medicine, 2001-10, Vol.132 (4), p.990-992

2001

Volltextzugriff (PDF)

Leptin and apoptosis inhibitor soluble Fas antigen in the serum of patients with osteosarcoma and neuroectodermal bone tumors

Bulletin of experimental biology and medicine, 2000-05, Vol.129 (5), p.496-498

2000

Volltextzugriff (PDF)

Optimization of in vivo crosslinking technique for the study of AlpB-protein interactions in Lysobacter sp. XL1 cells

Process biochemistry (1991), 2013-08, Vol.48 (8), p.1203-1207

2013

Volltextzugriff (PDF)

Monoclonal antibodies directed against unique and common determinants on the lipopolysaccharide molecule of Salmonella serogroups A, B, and D

Hybridoma, 1995-12, Vol.14 (6), p.557-562

1995

Volltextzugriff (PDF)

The library of human miniantibodies in the phage display format: designing and testing

Doklady. Biochemistry and biophysics, 2005-11, Vol.405 (1-6), p.437-440

2005

Volltextzugriff (PDF)

Soluble fas antigen in serum of cancer patients

Bulletin of experimental biology and medicine, 1999-03, Vol.127 (3), p.296-298

1999

Volltextzugriff (PDF)

Production and characterization of the monoclonal antibodies to Bacillus anthracis protective antigen

Russian journal of bioorganic chemistry, 2011-05, Vol.37 (3), p.316-321

2011

Volltextzugriff (PDF)

Preparation and characterization of monoclonal antibodies to Bacillus anthracis protective antigen

Bioorganicheskaia khimiia, 2011-05, Vol.37 (3), p.354

2011

Volltextzugriff (PDF)

Validation of an Analytical Procedure for Evaluating the Biological Activity of a Medicinal Product Based on Tocilizumab and Determination of Acceptance Criteria for Test Results

Regulatory Research and Medicine Evaluation, 2024-06, Vol.14 (3), p.317-329

2024

Volltextzugriff (PDF)

A fusion protein of Luciola mingrelica luciferase with a biotin-binding domain: Production, properties, and application

Moscow University chemistry bulletin, 2011-08, Vol.66 (4), p.241-246

2011

Volltextzugriff (PDF)

Monoclonal antibodies to botulinum neurotoxins of types A, B, E, and F

Russian journal of bioorganic chemistry, 2011-05, Vol.37 (3), p.307-315

2011

Volltextzugriff (PDF)

Monoclonal antibodies to type A, B, E and F botulinum neurotoxins

Bioorganicheskaia khimiia, 2011-05, Vol.37 (3), p.344

2011

Volltextzugriff (PDF)

Comparability of the Reference Drug Pulmozim and a Similar Drug Tigerase in Terms of their Pharmacodynamic, Toxicological and Pharmacokinetic Properties

Journal Biomed, 2023-04, Vol.19 (1), p.47-60

2023

Volltextzugriff (PDF)

Cell sensitivity to Fas-mediated apoptosis depends on three forms of Fas-antigen

Izvestiia Akademii nauk. Seriia biologicheskaia, 1998-03 (2), p.187

1998

Volltextzugriff (PDF)

Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit

Biopreparaty, 2021-10, Vol.21 (3), p.178-192

2021

Volltextzugriff (PDF)

Internalization of Recombinant Imiglucerase into Mouse Peritoneal Macrophages and L929 Mouse Fibroblasts

Biopreparaty, 2020-03, Vol.20 (1), p.42-49

2020

Volltextzugriff (PDF)

Expression of the apoptosis inhibitor soluble Fas antigen in patients with malignant and benign bone neoplasms

Vestnik Rossiĭskoĭ akademii medits︠i︡nskih nauk, 2001 (3), p.3

2001

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(101)
Russisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serum sFas, Leptin, and VEGF in Patients with Ovarian Cancer and Benign Tumors

Cancer and Soluble FAS

Method development and validation for determination of antihemolytic activity of eculizumab (Soliris)

Monoclonal antibodies against the propeptide of endopeptidase AlpB of Lysobacter sp. XL1 for studying AlpB-protein interactions in bacterial cells

Soluble Fas antigen in the serum of patients with colon cancer

Changes in the balance between membrane-bound and soluble forms of CD95 (Fas) during selection of tumor cells in vivo

Epitope mapping of human Fas using peptide phage display

Plasma content of soluble fas antigen in patients with adrenal tumors and tumor-like pathologies

Soluble Fas antigen (sFAS) in the serum from patients with adrenal tumors

Leptin and apoptosis inhibitor soluble Fas antigen in the serum of patients with osteosarcoma and neuroectodermal bone tumors

Optimization of in vivo crosslinking technique for the study of AlpB-protein interactions in Lysobacter sp. XL1 cells

Monoclonal antibodies directed against unique and common determinants on the lipopolysaccharide molecule of Salmonella serogroups A, B, and D

The library of human miniantibodies in the phage display format: designing and testing

Soluble fas antigen in serum of cancer patients

Production and characterization of the monoclonal antibodies to Bacillus anthracis protective antigen

Preparation and characterization of monoclonal antibodies to Bacillus anthracis protective antigen

Validation of an Analytical Procedure for Evaluating the Biological Activity of a Medicinal Product Based on Tocilizumab and Determination of Acceptance Criteria for Test Results

A fusion protein of Luciola mingrelica luciferase with a biotin-binding domain: Production, properties, and application

Monoclonal antibodies to botulinum neurotoxins of types A, B, E, and F

Monoclonal antibodies to type A, B, E and F botulinum neurotoxins

Comparability of the Reference Drug Pulmozim and a Similar Drug Tigerase in Terms of their Pharmacodynamic, Toxicological and Pharmacokinetic Properties

Cell sensitivity to Fas-mediated apoptosis depends on three forms of Fas-antigen

Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit

Internalization of Recombinant Imiglucerase into Mouse Peritoneal Macrophages and L929 Mouse Fibroblasts

Expression of the apoptosis inhibitor soluble Fas antigen in patients with malignant and benign bone neoplasms

Suchergebnisse filtern